b*******b
发帖数: 30 | 1 For only the second time, the Food and Drug Administration approved a
company's request to test an
embryonic stem cell-based therapy on human patients. Advanced Cell
Technology (ACT), based in
Marlborough, Mass., will begin testing its retinal cell treatment this year
in a dozen patients with Stargardt's
macular dystrophy, an inherited degenerative eye disease that leads to
blindness in children. In July, the FDA
released its hold on the first trial of an embryonic stem cell based
treatment, for spinal cord injury.
read more:http://healthland.time.com/2010/11/22/fda-approves-second-trial-of-stem-cell-
therapy/#more-17006 |
|
